Clinical trials
Recruiting Overweight trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 13 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 7 |
| AstraZeneca | 2 |
| Hoffmann-La Roche | 2 |
| Amgen | 1 |
| Federal University of Health Science of Porto Alegre | 1 |
| Federal University of Minas Gerais | 1 |
| Hospital de Clinicas de Porto Alegre | 1 |
| Instituto de Cardiologia do Rio Grande do Sul | 1 |
| Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques | 1 |
| Novo Nordisk A/S | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 21 |
| Overweight | 21 |
| Diabetes Mellitus, Type 2 | 4 |
| Diabetes Mellitus | 3 |
| Weight Loss | 2 |
| Atherosclerosis | 1 |
| Body Weight | 1 |
| Colitis, Ulcerative | 1 |
| Crohn Disease | 1 |
| Endocrine System Diseases | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.